Adnan Ali Alseidi, MD
General Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 2
- Since medical school
- 26 years
- Pennsylvania State University College of Medicine, 2000
Offices
2 locations · University of California Sfgh Medical Group · UCSF Dept of Surgery
Hospitals listed: UCSF Medical Center · Zuckerberg San Francisco General Hosp & Trauma Ctr. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alseidi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C167415 · Current
Licensed to practise in California · since 2019 · expires 2027-12-31 · Pennsylvania State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.60221749Physician And Surgeon License · since 2011 · expires 2021-09-26ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Surgery - Surgery
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
- Zuckerberg San Francisco General Hosp & Trauma CtrSan Francisco, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of San Francisco Health Network, which runs 2 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.449, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.37, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.538, Oct 2024 – Sep 2025
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Zuckerberg San Francisco General Hosp & Trauma Ctr
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.449 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.37 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.538 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 667 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.76 to 1.49) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 195.34 (147.34 to 243.34) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.5 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 214 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 261 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,351 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.5) · 4,709 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.39 (0.19 to 0.59) · 4,644 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.11 to 6.56) · 795 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.28) · 234 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.85 (1.33 to 4.38) · 861 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.95 (0.25 to 17.64) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6 (2.01 to 9.98) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 167 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.79 (0.08 to 1.49) · 4,129 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.709 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.769 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 41 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 227 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 28.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 75.1 · 239 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (8.3 to 15.1) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 132 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.4 to 17.9) · 966 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.7) · 88 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,644 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$48,337
Medicare paid this office $48,337 for 46 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Hernia repair - groin (open) | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal or exploration of parathyroid glands | 23 | – | – | – | – | – |
| Repair of abdomen using abdominal lining graft | 12 | – | – | – | – | – |
| Other procedure on liver using an endoscope | 11 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
46 Original Medicare patients in 2024. Average age 70 · Women 48% · Also on Medicaid 48% · Health risk score 1.59. At or below the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 72% · Coronary heart disease 35% · Cancer 30% · Chronic kidney disease 28% · Depression 24%.
The office billed $473,362, Medicare allowed $61,069 and paid $48,337; for 79 services of 42 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 46 | 79 | 70 | 1.59 | $473,362 | $48,337 |
| 2023 | 33 | 37 | 72 | 1.22 | $300,076 | $33,321 |
| 2022 | 32 | 46 | 70 | 1.30 | $307,151 | $38,663 |
| 2021 | 38 | 61 | 71 | 1.40 | $412,310 | $52,139 |
| 2020 | 28 | 42 | 72 | 2.00 | $92,818 | $24,879 |
| 2019 | 128 | 240 | 72 | 1.63 | $398,905 | $109,558 |
| 2018 | 138 | 304 | 72 | 1.37 | $556,234 | $123,758 |
| 2017 | 118 | 239 | 72 | 1.22 | $452,332 | $88,505 |
| 2016 | 149 | 335 | 72 | 1.22 | $624,360 | $137,919 |
| 2015 | 135 | 263 | 72 | 1.16 | $430,204 | $101,268 |
| 2014 | 139 | 298 | 71 | 1.41 | $394,295 | $105,143 |
| 2013 | 181 | 381 | 70 | 1.42 | $448,220 | $111,758 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 5 services
| Removal or exploration of parathyroid glands | 23 | $19,417 | $844 |
| Other procedure on liver using an endoscope | 11 | $7,159 | $651 |
| New patient visit (45+ min) | 58 | $6,193 | $107 |
| Repair of abdomen using abdominal lining graft | 12 | $3,170 | $264 |
| Ultrasonic guidance during surgery | 11 | $597 | $54 |
2018: 6 services
| Other procedure on liver using an endoscope | 27 | $30,669 | $1,136 |
| Removal or exploration of parathyroid glands | 11 | $8,967 | $815 |
| New patient visit (45+ min) | 71 | $7,488 | $105 |
| Other procedure on abdomen using an endoscope | 17 | $3,312 | $184 |
| Ultrasonic guidance during surgery | 20 | $1,063 | $53 |
| New patient visit (30+ min) | 15 | $839 | $56 |
2017: 4 services
| Other procedure on liver using an endoscope | 17 | $17,940 | $944 |
| Removal or exploration of parathyroid glands | 16 | $12,526 | $783 |
| New patient visit (45+ min) | 69 | $7,219 | $105 |
| New patient visit (30+ min) | 13 | $761 | $59 |
2016: 7 services
| Partial removal of pancreas, bile duct, and small bowel with connection of pancreas to small bowel | 12 | $21,603 | $1,800 |
| Removal or exploration of parathyroid glands | 20 | $15,765 | $788 |
| Other procedure on liver using an endoscope | 14 | $15,597 | $1,040 |
| New patient visit (45+ min) | 51 | $5,305 | $104 |
| Repair of abdomen using abdominal lining graft | 17 | $3,623 | $213 |
| New patient visit (30+ min) | 37 | $2,167 | $59 |
| Ultrasonic guidance during surgery | 13 | $603 | $46 |
2015: 5 services
| Removal or exploration of parathyroid glands | 16 | $12,598 | $787 |
| New patient visit (45+ min) | 58 | $6,158 | $106 |
| Repair of abdomen using abdominal lining graft | 13 | $2,727 | $210 |
| New patient visit (30+ min) | 20 | $1,187 | $59 |
| New patient visit (15+ min) | 11 | $452 | $41 |
2014: 4 services
| New patient visit (45+ min) | 68 | $7,200 | $106 |
| Short return visit (20+ min) | 19 | $971 | $42 |
| New patient visit (30+ min) | 12 | $729 | $61 |
| Short return visit | 29 | $684 | $21 |
2013: 7 services
| Removal or exploration of parathyroid glands | 21 | $15,777 | $751 |
| New patient visit (45+ min) | 79 | $8,263 | $105 |
| Insertion of central venous tube with port (5 years or older) | 14 | $4,799 | $300 |
| Return visit (30+ min) | 29 | $1,908 | $62 |
| Short return visit (20+ min) | 37 | $1,648 | $41 |
| New patient visit (30+ min) | 20 | $1,244 | $62 |
| Short return visit | 11 | $223 | $20 |
Drugs they prescribed that Part D paid
$8,430
Pharmacies billed $8,430 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 17) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
11 generic and fewer than 11 brand-name prescriptions · $8,430 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 17 | None | 0% (0) | None | $8,430 |
| 2022 | 20 | None | 0% (0) | None | $704 |
| 2021 | 23 | 11 | 0% (0) | None | $564 |
| 2019 | 19 | None | None | 63% | $3,957 |
| 2017 | 26 | 12 | None | 50% | $11,326 |
| 2016 | 33 | 14 | None | 64% | $10,460 |
| 2014 | 22 | 13 | None | None | $241 |
| 2013 | 16 | 14 | 69% (11) | None | $211 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 1 drug
| Creon | 12 | $3,925 | $327 |
2017: 1 drug
| Creon | 13 | $11,185 | $860 |
2016: 1 drug
| Creon | 14 | $8,729 | $623 |
Money from drug and device companies
$10,014 in 2025
| 2025 | 5 | 25 | $7,621 | $10,014 |
| 2024 | 8 | 18 | $18,856 | $19,605 |
| 2023 | 8 | 46 | $38,854 | $43,620 |
| 2022 | 9 | 28 | $25,725 | $28,535 |
| 2021 | 6 | 34 | $41,297 | $43,642 |
| 2020 | 5 | 19 | $36,542 | $37,231 |
| 2019 | 4 | 41 | $52,594 | $57,203 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Applied Medical Resources | Gelport Laparoscopic System | $6,512 | 9 payments
|
| Medical Device Business Services | Surgicel Nu-Knit | $2,154 | 8 payments
|
| Ethicon US | Surgicel Nu-Knit | $1,145 | 6 payments
|
| Dilon Technologies | Hemoblast Bellows | $175 | 1 payment
|
| Integra LifeSciences | Codman Certas | $28 | 1 payment
|
See all 25 published payments
| Applied Medical Resources | Consulting · 2025-12-23 | Gelport Laparoscopic System | $1,750 |
| Medical Device Business Services | Consulting · 2025-12-02 | Surgicel Nu-Knit | $1,122 |
| Ethicon US | Meals · 2025-11-11 | Vistaseal | $133 |
| Applied Medical Resources | Consulting · 2025-11-05 | Gelport Laparoscopic System | $219 |
| Ethicon US | Consulting · 2025-10-29 | Surgicel Nu-Knit | $561 |
| Applied Medical Resources | Consulting · 2025-10-29 | None | $219 |
| Medical Device Business Services | Meals · 2025-10-11 | None | $48 |
| Medical Device Business Services | Meals · 2025-10-11 | None | $35 |
| Medical Device Business Services | Meals · 2025-10-11 | None | $61 |
| Medical Device Business Services | Meals · 2025-10-10 | None | $144 |
| Medical Device Business Services | Travel · 2025-10-10 | None | $397 |
| Medical Device Business Services | Travel · 2025-10-10 | None | $272 |
| Medical Device Business Services | Travel · 2025-10-10 | None | $75 |
| Applied Medical Resources | Consulting · 2025-08-06 | None | $3,000 |
| Applied Medical Resources | Travel · 2025-08-06 | None | $574 |
| Applied Medical Resources | Consulting · 2025-07-23 | None | $106 |
| Applied Medical Resources | Consulting · 2025-07-23 | None | $81 |
| Ethicon US | Meals · 2025-07-21 | Echelon Endopath | $99 |
| Applied Medical Resources | Consulting · 2025-07-09 | Gelport Laparoscopic System | $188 |
| Ethicon US | Meals · 2025-06-20 | Evarrest | $98 |
| Ethicon US | Meals · 2025-06-12 | Echelon; Endopath | $113 |
| Dilon Technologies | Meals · 2025-03-21 | Hemoblast Bellows | $175 |
| Integra LifeSciences | Meals · 2025-03-20 | Codman Certas | $28 |
| Ethicon US | Meals · 2025-02-03 | Stratafix | $141 |
| Applied Medical Resources | Consulting · 2025-01-29 | None | $375 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $19,605
| BK Medical Holding Company | Bk3000, Bk3500 & Bk5000 Ultrasound System | $11,125 | 3 payments
|
| Applied Medical Resources | None | $3,670 | 4 payments
|
| Ethicon US | Surgicel Nu-Knit | $2,388 | 4 payments
|
| Medical Device Business Services | Surgicel Nu-Knit | $1,142 | 2 payments
|
| Integra LifeSciences | Integra | $1,108 | 2 payments
|
| Medtronic | Signia | $82 | 1 payment
|
| W. L. Gore & Associates | Gore Seamguard Bioabsorbable Staple Line Reinforce | $53 | 1 payment
|
| Ethicon | Monarch Platform | $36 | 1 payment
|
2023: $43,620
| Medical Device Business Services | Surgicel Nu-Knit | $21,302 | 19 payments
|
| Integra LifeSciences | Codman Certas | $11,740 | 7 payments
|
| Ethicon | Surgicel Nu-Knit | $8,924 | 7 payments
|
| Applied Medical Resources | None | $750 | 2 payments
|
| Ethicon US | Echelon Flex | $411 | 7 payments
|
| Stryker | 1688 | $288 | 2 payments
|
| Dilon Technologies | Hemoblast Bellows | $172 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $33 | 1 payment
|
2022: $28,535
| Integra LifeSciences | Codman Certas | $9,921 | 8 payments
|
| Ethicon | None | $8,593 | 4 payments
|
| Medical Device Business Services | Surgicel Nu-Knit | $5,610 | 2 payments
|
| Ethicon Endo-Surgery | None | $1,683 | 1 payment
|
| Ethicon US | Evarrest | $1,265 | 5 payments
|
| Applied Medical Resources | Gelpoint V-Path | $715 | 3 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $451 | 3 payments
|
| Stryker | 1688 | $170 | 1 payment
|
| Medtronic | Valleylab Ft10 | $127 | 1 payment
|
2021: $43,642
| Medical Device Business Services | Surgicel Nu-Knit | $38,364 | 15 payments
|
| Ethicon US | Evarrest | $3,726 | 8 payments
|
| Stryker | None | $781 | 6 payments
|
| Ethicon | None | $561 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $150 | 3 payments
|
| Medtronic | Ligasure | $60 | 1 payment
|
2020: $37,231
| Medical Device Business Services | Neuwave Flex Microwave Ablation System | $35,872 | 11 payments
|
| Ethicon | Evicel Fibrin Sealant (Human) | $755 | 1 payment
|
| Ethicon US | Vistaseal | $341 | 4 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $186 | 2 payments
|
| Sirtex Medical | Sir-Spheres Microspheres | $77 | 1 payment
|
2019: $57,203
| Medical Device Business Services | Certus 140 Microwave Ablation System | $56,239 | 35 payments
|
| Ethicon US | Certus 140 Microwave Ablation System | $515 | 3 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $308 | 2 payments
|
| AngioDynamics | None | $140 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1821078379
- Licence
- CA C167415, MO 2010008190, WA MD60221749California C167415: Current · expires 2027-12-31Washington MD.MD.60221749: Expired
- Trained
- Pennsylvania State University College of Medicine, 2000 · 26 years ago
- Group
- University of California Sfgh Medical Group · UCSF Dept of Surgery
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 1821078379
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 400 Parnassus Ave, San Francisco, CA, 94143
- NPI first listed
- 2006-01-19
- NPI last updated
- 2020-01-16
- NPI record certified
- 2020-01-16
This is when the NPI record was last certified, not a medical board exam.